2291 — Lepu Scientech Medical Technology Shanghai Co Income Statement
0.000.00%
Last trade - 00:00
- HK$4.92bn
- HK$3.55bn
- CNY325.90m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 116 | 148 | 223 | 248 | 326 |
Cost of Revenue | |||||
Gross Profit | 103 | 133 | 198 | 220 | 289 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 56.2 | 71.7 | 146 | 249 | 167 |
Operating Profit | 60.2 | 76.5 | 76.4 | -1.73 | 159 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 60.3 | 76.7 | 66 | -15 | 173 |
Provision for Income Taxes | |||||
Net Income After Taxes | 51.9 | 68.8 | 58.7 | -19.8 | 152 |
Net Income Before Extraordinary Items | |||||
Net Income | 51.9 | 68.8 | 58.7 | -19.8 | 152 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 51.9 | 68.8 | 58.7 | -19.8 | 152 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.15 | 0.198 | 0.253 | -0.02 | 0.437 |
Dividends per Share |